<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26906558</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.</ArticleTitle><Pagination><StartPage>22002</StartPage><MedlinePgn>22002</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22002</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep22002</ELocationID><Abstract><AbstractText>When retinoic acid-inducible gene 1 protein (RIG-I)-like receptors sense viral dsRNA in the cytosol, RIG-I and melanoma differentiation-associated gene 5 (MDA5) are recruited to the mitochondria to interact with mitochondrial antiviral signaling protein (MAVS) and initiate antiviral immune responses. In this study, we demonstrate that the biotin-containing enzyme pyruvate carboxylase (PC) plays an essential role in the virus-triggered activation of nuclear factor kappa B (NF-&#x3ba;B) signaling mediated by MAVS. PC contributes to the enhanced production of type I interferons (IFNs) and pro-inflammatory cytokines, and PC knockdown inhibits the virus-triggered innate immune response. In addition, PC shows extensive antiviral activity against RNA viruses, including influenza A virus (IAV), human enterovirus 71 (EV71), and vesicular stomatitis virus (VSV). Furthermore, PC mediates antiviral action by targeting the MAVS signalosome and induces IFNs and pro-inflammatory cytokines by promoting phosphorylation of NF-&#x3ba;B inhibitor-&#x3b1; (I&#x3ba;B&#x3b1;) and the I&#x3ba;B kinase (IKK) complex, as well as NF-&#x3ba;B nuclear translocation, which leads to activation of interferon-stimulated genes (ISGs), including double-stranded RNA-dependent protein kinase (PKR) and myxovirus resistance protein 1 (Mx1). Our findings suggest that PC is an important player in host antiviral signaling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Zhongying</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yaqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shengli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xueyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Nanfang</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaodan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505371">MAVS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>139874-52-5</RegistryNumber><NameOfSubstance UI="D000072000">NF-KappaB Inhibitor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.12.-</RegistryNumber><NameOfSubstance UI="D008156">Luciferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000602769">EIF2AK2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D019892">eIF-2 Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452820">RIGI protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.4.1.1</RegistryNumber><NameOfSubstance UI="D011766">Pyruvate Carboxylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072000" MajorTopicYN="N">NF-KappaB Inhibitor alpha</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011766" MajorTopicYN="N">Pyruvate Carboxylase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018116" MajorTopicYN="N">Vesiculovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019892" MajorTopicYN="N">eIF-2 Kinase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26906558</ArticleId><ArticleId IdType="pmc">PMC4764940</ArticleId><ArticleId IdType="doi">10.1038/srep22002</ArticleId><ArticleId IdType="pii">srep22002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akira S., Uematsu S. &amp; Takeuchi O. Pathogen recognition and innate immunity. Cell 124, 783&#x2013;801, doi: 10.1016/j.cell.2006.02.015 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiscott J. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev 18, 483&#x2013;490, doi: 10.1016/j.cytogfr.2007.06.002 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2007.06.002</ArticleId><ArticleId IdType="pubmed">17706453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6, 981&#x2013;988, doi: 10.1038/ni1243 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1243</ArticleId><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K. &amp; Akira S. Toll-like receptors in innate immunity. Int Immunol 17, 1&#x2013;14, doi: 10.1093/intimm/dxh186 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxh186</ArticleId><ArticleId IdType="pubmed">15585605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T. &amp; Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637&#x2013;650, doi: 10.1016/j.immuni.2011.05.006 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.006</ArticleId><ArticleId IdType="pubmed">21616434</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo Y. M. &amp; Gale M. Jr. Immune signaling by RIG-I-like receptors. Immunity 34, 680&#x2013;692, doi: 10.1016/j.immuni.2011.05.003 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.003</ArticleId><ArticleId IdType="pmc">PMC3177755</ArticleId><ArticleId IdType="pubmed">21616437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730&#x2013;737, doi: 10.1038/ni1087 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1087</ArticleId><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T. et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 104, 582&#x2013;587, doi: 10.1073/pnas.0606699104 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606699104</ArticleId><ArticleId IdType="pmc">PMC1766428</ArticleId><ArticleId IdType="pubmed">17190814</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175, 2851&#x2013;2858 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16116171</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J. L. &amp; Coyne C. B. Mechanisms of MAVS regulation at the mitochondrial membrane. J Mol Biol 425, 5009&#x2013;5019, doi: 10.1016/j.jmb.2013.10.007 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.10.007</ArticleId><ArticleId IdType="pmc">PMC4562275</ArticleId><ArticleId IdType="pubmed">24120683</ArticleId></ArticleIdList></Reference><Reference><Citation>Meylan E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167&#x2013;1172, doi: 10.1038/nature04193 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04193</ArticleId><ArticleId IdType="pubmed">16177806</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth R. B., Sun L., Ea C. K. &amp; Chen Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669&#x2013;682, doi: 10.1016/j.cell.2005.08.012 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19, 727&#x2013;740, doi: 10.1016/j.molcel.2005.08.014 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.08.014</ArticleId><ArticleId IdType="pubmed">16153868</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M., Onomoto K., Jogi M., Akaboshi T. &amp; Fujita T. Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol 32, 48&#x2013;53, doi: 10.1016/j.coi.2014.12.012 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2014.12.012</ArticleId><ArticleId IdType="pubmed">25594890</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo B. &amp; Cheng G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 282, 11817&#x2013;11826, doi: 10.1074/jbc.M700017200 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M700017200</ArticleId><ArticleId IdType="pubmed">17327220</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491&#x2013;496, doi: 10.1038/ni921 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Michallet M. C. et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28, 651&#x2013;661, doi: 10.1016/j.immuni.2008.03.013 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.03.013</ArticleId><ArticleId IdType="pubmed">18439848</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V. et al. 5&#x2032;-Triphosphate RNA is the ligand for RIG-I. Science 314, 994&#x2013;997, doi: 10.1126/science.1132505 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132505</ArticleId><ArticleId IdType="pubmed">17038590</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakhaei P., Genin P., Civas A. &amp; Hiscott J. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin Immunol 21, 215&#x2013;222, doi: 10.1016/j.smim.2009.05.001 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2009.05.001</ArticleId><ArticleId IdType="pubmed">19539500</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630, doi: 10.1126/science.aaa2630 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa2630</ArticleId><ArticleId IdType="pubmed">25636800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia P. et al. IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation. Nat Commun 6, 8132, doi: 10.1038/ncomms9132 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9132</ArticleId><ArticleId IdType="pmc">PMC4569712</ArticleId><ArticleId IdType="pubmed">26348439</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin J. E. et al. Type I IFN modulates innate and specific antiviral immunity. J Immunol 164, 4220&#x2013;4228 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10754318</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D. E. &amp; Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12, 143&#x2013;156 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11325598</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D. E. &amp; Marie I. J. RIGging an antiviral defense&#x2013;it&#x2019;s in the CARDs. Nat Immunol 5, 699&#x2013;701, doi: 10.1038/ni0704-699 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni0704-699</ArticleId><ArticleId IdType="pubmed">15224097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lietzan A. D. &amp; St Maurice M. Functionally diverse biotin-dependent enzymes with oxaloacetate decarboxylase activity. Arch Biochem Biophys 544, 75&#x2013;86, doi: 10.1016/j.abb.2013.10.014 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2013.10.014</ArticleId><ArticleId IdType="pubmed">24184447</ArticleId></ArticleIdList></Reference><Reference><Citation>Jitrapakdee S. et al. Structure, mechanism and regulation of pyruvate carboxylase. Biochem J 413, 369&#x2013;387, doi: 10.1042/BJ20080709 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20080709</ArticleId><ArticleId IdType="pmc">PMC2859305</ArticleId><ArticleId IdType="pubmed">18613815</ArticleId></ArticleIdList></Reference><Reference><Citation>Jitrapakdee S., Vidal-Puig A. &amp; Wallace J. C. Anaplerotic roles of pyruvate carboxylase in mammalian tissues. Cell Mol Life Sci 63, 843&#x2013;854, doi: 10.1007/s00018-005-5410-y (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-005-5410-y</ArticleId><ArticleId IdType="pmc">PMC11136034</ArticleId><ArticleId IdType="pubmed">16505973</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen O. E., Kalhan S. C. &amp; Hanson R. W. The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 277, 30409&#x2013;30412, doi: 10.1074/jbc.R200006200 (2002).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R200006200</ArticleId><ArticleId IdType="pubmed">12087111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellers K. et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Invest 125, 687&#x2013;698, doi: 10.1172/JCI72873 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72873</ArticleId><ArticleId IdType="pmc">PMC4319441</ArticleId><ArticleId IdType="pubmed">25607840</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonpho A., Rojvirat P., Jitrapakdee S. &amp; MacDonald M. J. Characterization of the distal promoter of the human pyruvate carboxylase gene in pancreatic beta cells. PLoS One 8, e55139, doi: 10.1371/journal.pone.0055139 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055139</ArticleId><ArticleId IdType="pmc">PMC3559343</ArticleId><ArticleId IdType="pubmed">23383084</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson B. H. Lactic acidemia and mitochondrial disease. Mol Genet Metab 89, 3&#x2013;13, doi: 10.1016/j.ymgme.2006.05.015 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2006.05.015</ArticleId><ArticleId IdType="pubmed">16854608</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X. et al. Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin. Cancer Res 70, 1204&#x2013;1214, doi: 10.1158/0008-5472.CAN-09-3321 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-09-3321</ArticleId><ArticleId IdType="pubmed">20103628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. H. et al. Toxicity generated through inhibition of pyruvate carboxylase and carnitine palmitoyl transferase-1 is similar to high glucose/palmitate-induced glucolipotoxicity in INS-1 beta cells. Mol Cell Endocrinol 383, 48&#x2013;59, doi: 10.1016/j.mce.2013.12.002 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2013.12.002</ArticleId><ArticleId IdType="pubmed">24333689</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S. S., Kim S. J., Choi H., Chang C. &amp; Kim E. TR4 promotes fatty acid synthesis in 3T3-L1 adipocytes by activation of pyruvate carboxylase expression. FEBS Lett 588, 3947&#x2013;3953, doi: 10.1016/j.febslet.2014.09.007 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.09.007</ArticleId><ArticleId IdType="pubmed">25240193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeczycki T. N., Maurice M. S. &amp; Attwood P. V. Inhibitors of Pyruvate Carboxylase. Open Enzym Inhib J 3, 8&#x2013;26, doi: 10.2174/1874940201003010008 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874940201003010008</ArticleId><ArticleId IdType="pmc">PMC3238542</ArticleId><ArticleId IdType="pubmed">22180764</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli E. K. et al. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4, e1000196, doi: 10.1371/journal.ppat.1000196 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000196</ArticleId><ArticleId IdType="pmc">PMC2572141</ArticleId><ArticleId IdType="pubmed">18989459</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott J. et al. New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells. PLoS One 5, e11159, doi: 10.1371/journal.pone.0011159 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011159</ArticleId><ArticleId IdType="pmc">PMC2887373</ArticleId><ArticleId IdType="pubmed">20567522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell A. M. &amp; Gale M. Jr. RIG-I in RNA virus recognition. Virology 479&#x2013;480C, 110&#x2013;121, doi: 10.1016/j.virol.2015.02.017 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.017</ArticleId><ArticleId IdType="pmc">PMC4424084</ArticleId><ArticleId IdType="pubmed">25749629</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo Y. M. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82, 335&#x2013;345, doi: 10.1128/JVI.01080-07 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01080-07</ArticleId><ArticleId IdType="pmc">PMC2224404</ArticleId><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P. et al. UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS. Cell Rep 3, 1057&#x2013;1070, doi: 10.1016/j.celrep.2013.02.027 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.02.027</ArticleId><ArticleId IdType="pmc">PMC3707122</ArticleId><ArticleId IdType="pubmed">23545497</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25, 6685&#x2013;6705, doi: 10.1038/sj.onc.1209934 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209934</ArticleId><ArticleId IdType="pubmed">17072322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden M. S., West A. P. &amp; Ghosh S. NF-kappaB and the immune response. Oncogene 25, 6758&#x2013;6780, doi: 10.1038/sj.onc.1209943 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209943</ArticleId><ArticleId IdType="pubmed">17072327</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim S. A., Lim Y. S., Kim J. W. &amp; Hwang S. B. Nonstructural 5A protein of hepatitis C virus interacts with pyruvate carboxylase and modulates viral propagation. PLoS One 8, e68170, doi: 10.1371/journal.pone.0068170 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068170</ArticleId><ArticleId IdType="pmc">PMC3701667</ArticleId><ArticleId IdType="pubmed">23861867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C. Q. et al. ECSIT bridges RIG-I-like receptors to VISA in signaling events of innate antiviral responses. J Innate Immun 7, 153&#x2013;164, doi: 10.1159/000365971 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000365971</ArticleId><ArticleId IdType="pmc">PMC6738808</ArticleId><ArticleId IdType="pubmed">25228397</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X. Y., Wei B., Shi H. X., Shan Y. F. &amp; Wang C. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res 20, 994&#x2013;1011, doi: 10.1038/cr.2010.103 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.103</ArticleId><ArticleId IdType="pubmed">20628368</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue J., Gohda J. &amp; Akiyama T. Characteristics and biological functions of TRAF6. Adv Exp Med Biol 597, 72&#x2013;79 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17633018</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki K. et al. Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci Signal 2, ra66, doi: 10.1126/scisignal.2000387 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2000387</ArticleId><ArticleId IdType="pubmed">19843958</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q. et al. Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses. J Virol 87, 11244&#x2013;11254, doi: 10.1128/JVI.01248-13 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01248-13</ArticleId><ArticleId IdType="pmc">PMC3807281</ArticleId><ArticleId IdType="pubmed">23946454</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y. et al. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2. J Immunol 187, 4844&#x2013;4860, doi: 10.4049/jimmunol.1100998 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100998</ArticleId><ArticleId IdType="pubmed">21957142</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S. et al. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology 56, 57&#x2013;66, doi: 10.1002/hep.25642 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.25642</ArticleId><ArticleId IdType="pubmed">22318991</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushima-Miyagi T. et al. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles. Clin Cancer Res 18, 6271&#x2013;6283, doi: 10.1158/1078-0432.CCR-12-1595 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-12-1595</ArticleId><ArticleId IdType="pubmed">23014529</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W. et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 3, e1985, doi: 10.1371/journal.pone.0001985 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001985</ArticleId><ArticleId IdType="pmc">PMC2288676</ArticleId><ArticleId IdType="pubmed">18414668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhtar M. M. et al. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription. Int J Biochem Cell Biol 41, 554&#x2013;560, doi: 10.1016/j.biocel.2008.07.001 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2008.07.001</ArticleId><ArticleId IdType="pubmed">18687409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X. et al. MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell 158, 607&#x2013;619, doi: 10.1016/j.cell.2014.05.047 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.05.047</ArticleId><ArticleId IdType="pmc">PMC4119298</ArticleId><ArticleId IdType="pubmed">25083871</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>